Dantrolene acts to reduce which of the following in malignant hyperthermia?

Prepare for the EDAPT Intracranial Regulation Test with interactive flashcards and multiple choice questions. Each question is accompanied by helpful hints and explanations to boost your readiness. Get started today and ensure your success!

Multiple Choice

Dantrolene acts to reduce which of the following in malignant hyperthermia?

Explanation:
Dantrolene works by limiting calcium release from the skeletal muscle's sarcoplasmic reticulum, which reduces the calcium available for muscle contraction. In malignant hyperthermia, excessive calcium release causes sustained muscle contraction and a dangerous hypermetabolic state. By lowering intracellular calcium, dantrolene relaxes the muscles and slows the excessive metabolic activity, thereby reducing muscle rigidity. It doesn't directly change nerve conduction velocity, blood glucose, or platelet aggregation, which is why the key effect in this condition is the relief of rigidity.

Dantrolene works by limiting calcium release from the skeletal muscle's sarcoplasmic reticulum, which reduces the calcium available for muscle contraction. In malignant hyperthermia, excessive calcium release causes sustained muscle contraction and a dangerous hypermetabolic state. By lowering intracellular calcium, dantrolene relaxes the muscles and slows the excessive metabolic activity, thereby reducing muscle rigidity. It doesn't directly change nerve conduction velocity, blood glucose, or platelet aggregation, which is why the key effect in this condition is the relief of rigidity.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy